Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

2021 saw a slow return to normalcy and increased scientific engagement despite COVID-19 challenges.

More precise, personalized therapies are needed for autoimmune diseases.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Understanding how acne develops in different diseases could lead to new treatments.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.